FITZGERALD THOMAS A (VP, Chief Financial Officer) purchased 708.2% of their position (49.35K shares) of TRANSCODE THERAPEUTICS, INC. on the open market
Open‑market purchase worth $25.2K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 10/2/2023ACC: 0001104659-23-105925
DirectorOfficer· VP, Chief Financial Officer
Since Jul 2021
+49.35K
Net shares
Net buyer
$25.2K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
49.35K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+49.35K
Price / share
$0.51
Trade value
$25.17K
% of position
708.2%
9/28/2023
6.97K→56.32K
Total
Net shares
+49.35K
Net value
$25.17K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/28/2023 | P · Purchase | +49.35K | $0.51 | $25.17K | 708.2% | 6.97K | 56.32K |
| Total | +49.35K | $25.17K | ||||||
Derivative Transactions0
No derivative transactions reported